282 related articles for article (PubMed ID: 26590787)
21. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
[TBL] [Abstract][Full Text] [Related]
22. Functional imaging of atherosclerosis to advance vascular biology.
Sakalihasan N; Michel JB
Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):728-34. PubMed ID: 19232504
[TBL] [Abstract][Full Text] [Related]
23. Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.
Crișan G; Moldovean-Cioroianu NS; Timaru DG; Andrieș G; Căinap C; Chiș V
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563414
[TBL] [Abstract][Full Text] [Related]
24. SPECT Versus PET Myocardial Perfusion Imaging in Patients with Equivocal CT.
Singh V; Di Carli MF
Curr Cardiol Rep; 2020 May; 22(6):43. PubMed ID: 32451746
[TBL] [Abstract][Full Text] [Related]
25. Incremental prognostic value of sequential imaging of single-photon emission computed tomography and coronary computed tomography angiography in patients with suspected coronary artery disease.
Kim HL; Kim YJ; Lee SP; Park EA; Paeng JC; Kim HK; Lee W; Cho GY; Zo JH; Choi DJ; Sohn DW
Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):878-85. PubMed ID: 24497522
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
[TBL] [Abstract][Full Text] [Related]
27. [Positron emission tomography for molecular imaging of prostate cancer].
Shen GH; Zhang WJ; Jia ZY; Deng HF
Zhonghua Nan Ke Xue; 2014 Nov; 20(11):1039-42. PubMed ID: 25577843
[TBL] [Abstract][Full Text] [Related]
28. ⁹⁰Y-based PET and SPECT/CT imaging in locoregional brain treatment for high-grade gliomas: retrospective fusion with MRI.
Fabbri C; Mattone V; Sarti G; Casi M; De Lauro F; Agostini M; Bartolini N; Bartolomei M
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1822-3. PubMed ID: 22872309
[No Abstract] [Full Text] [Related]
29. New molecular targets for PET and SPECT imaging in neurodegenerative diseases.
Benadiba M; Luurtsema G; Wichert-Ana L; Buchpigel CA; Busatto Filho G
Braz J Psychiatry; 2012 Oct; 34 Suppl 2():S125-36. PubMed ID: 23429844
[TBL] [Abstract][Full Text] [Related]
30. Technical Aspects of Cardiac PET Imaging and Recent Advances.
Germano G; Berman DS; Slomka P
Cardiol Clin; 2016 Feb; 34(1):13-23. PubMed ID: 26590776
[TBL] [Abstract][Full Text] [Related]
31. PET-Based Imaging of Ischemic Heart Disease.
Chen K; Miller EJ; Sadeghi MM
PET Clin; 2019 Apr; 14(2):211-221. PubMed ID: 30826019
[TBL] [Abstract][Full Text] [Related]
32. PET/CT and vascular disease: current concepts.
Cavalcanti Filho JL; de Souza Leão Lima R; de Souza Machado Neto L; Kayat Bittencourt L; Domingues RC; da Fonseca LM
Eur J Radiol; 2011 Oct; 80(1):60-7. PubMed ID: 21371842
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis.
Jaarsma C; Leiner T; Bekkers SC; Crijns HJ; Wildberger JE; Nagel E; Nelemans PJ; Schalla S
J Am Coll Cardiol; 2012 May; 59(19):1719-28. PubMed ID: 22554604
[TBL] [Abstract][Full Text] [Related]
34. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
[TBL] [Abstract][Full Text] [Related]
35. PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow.
Orbay H; Hong H; Zhang Y; Cai W
Angiogenesis; 2013 Apr; 16(2):279-87. PubMed ID: 23117521
[TBL] [Abstract][Full Text] [Related]
36. [New challenges and perspectives in nuclear medicine imaging].
Borbély K
Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
[TBL] [Abstract][Full Text] [Related]
37. PET/CT and SPECT/CT cardiac fusion imaging in a patient with takotsubo cardiomyopathy.
Miyachi H; Kumita S; Tanaka K
Eur Heart J; 2013 Feb; 34(5):397. PubMed ID: 22922294
[No Abstract] [Full Text] [Related]
38. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
[TBL] [Abstract][Full Text] [Related]
39. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
40. Molecular imaging agents for SPECT (and SPECT/CT).
Gnanasegaran G; Ballinger JR
Eur J Nucl Med Mol Imaging; 2014 May; 41 Suppl 1():S26-35. PubMed ID: 24318159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
